Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?

Lignende værker

• Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?
  af: Zareba, Piotr, et al.
  Udgivet: (2015)
• Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention
  af: Zareba, Piotr, et al.
  Udgivet: (2018)
• Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism
  af: Hu, Jim C., et al.
  Udgivet: (2012)
• Androgen deprivation therapy for prostate cancer is associated in increased risk for biliary disease
  af: Saylor, Philip J., et al.
  Udgivet: (2013)
• Follicle-stimulating hormone: A potential surrogate marker for androgen deprivation therapy oncological and systemic effects
  af: Pinthus, Jehonathan H.
  Udgivet: (2015)